1. Bennett S. The role of community-based health insurance within the health care financing system: A framework for analysis. Health Policy Plan. 2004;19:147–158.
2. Carrin G, Waelkens MP, Criel B. Community-based health insurance in developing countries: A study of its contribution to the performance of health financing systems. Trop Med Int Health. 2005;10:799–811.
3. Clinton Foundation. Distribution of artemisinin-based combination therapies through private sector channels: Lessons from four country case studies. New York: Clinton Foundation; 2008.
4. Ekman B. Community-based health insurance in low-income countries: A systematic review of the evidence. Health Policy Plann. 2004;19:249–270.
5. Fapohunda BM, Beth AP, Robert A, et al. Home-based management of fever strategy in Uganda: A report of the 2003 survey. Arlington, VA: MOH, WHO and BASICS II; 2004.
6. Goodman CA. An economic analysis of the retail market for fever and malaria treatment in rural Tanzania. Thesis submitted to the University of London for the Degree of Doctor of Philosophy. London: London School of Hygiene and Tropical Medicine, Health Policy Unit; 2004.
7. Grilli R, Ramsay C, Minozzi S. Mass media interventions: Effects on health services utilisation. Cochrane Database Syst Rev. 2002;(1);1:CD000389.
8. Ikeoluwapo OA, Browne EN, Garshong B, et al. Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. Malaria J. 2008;7:6.
9. Kutzin J, Barnum H. How health insurance affects the delivery of health care in developing countries. World Bank technical paper. Washington DC: World Bank; 1992.
10. Lagaarde M, Palmer N. Evidence from systematic reviews to inform decision making regarding financing mechanisms that improve access to health services for poor people. A policy brief prepared for the International Dialogue on Evidence-Informed Action to Achieve Health Goals in Developing Countries (IDEAHealth). Geneva: Alliance for Health Policy and Systems Research; 2006. http://www.who.int/rpc/meetings/HealthFinancingBrief.pdf. (accessed February 28, 2008) 11. Lewin SA, Babigumira SM, Bosch-Capblanch X, et al. Lay health workers in primary and community health care: A systematic review of trials. Geneva: Alliance for Health Policy and Systems Research; 2006. www.who.int/rpc/meetings/LHW_review.pdf. (accessed December 24, 2009)
12. Ministry of Health. Antimalarial treatment policy change to ACTs. Kampala, Uganda: Ministry of Health; 2005.
13. Ministry of Health. Management of uncomplicated malaria. A practical guide for health workers. 3rd ed. Kampala, Uganda: Ministry of Health Malaria Control Programme; 2005.
14. Ministry of Health. National guidelines for treatment. Diagnosis and prevention of malaria in Kenya. Nairobi, Kenya: Ministry of Health; 2006.
15. Ministry of Health. The guidelines for malaria diagnosis and treatment. Zanzibar: United Republic of Tanzania: Ministry of Health; 2007.
16. Ranson MK. Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: Current experiences and challenges. Bull World Health Organ. 2002;80:613–621.
17. Samarasekera U. Drug subsidy could help Tanzania tackle malaria. Lancet. 2008;371:1403–1406.
18. Waters H, Hatt L, Peters D. Working with the private sector for child health. Health Policy Plan. 2003;18:127–137.
19. World Health Organization. Antimalarial drug combination therapy. Report of a WHO technical consultation. Geneva, Switzerland: World Health Organization; 2001.
21. World Health Organization. Guidelines for the treatment of malaria. Geneva, Switzerland: World Health Organization; 2006.
22. World Health Organization. The use of artemisinin and its derivatives as antimalarial drugs: A report of a joint CTD/DMP/TDR Informal Consultation. Geneva: World Health Organization; 1998. WHO/MAL/98.1086
23. World Health Organization. World malaria report 2008. Geneva: Global Malaria Programme; 2008. WHO/HTM/GMP/2008.
24. Yeboah-Antwi K, Gyapong JO, Asare IK, et al. Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment. Bull World Health Organ. 2001;79:394–399.